| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ari-3037mo | diacylglycerol o-acyltransferase 2 | NA | Successful target | TTD , DGIDB | Hypertriglyceridemia[MeSHID:D015228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Dyslipidemias[MeSHID:D050171] |
NA | phase 2 | unknown |
| ari-3037mo | nicotinic acid receptor | NA | Successful target | TTD , DGIDB | Hypertriglyceridemia[MeSHID:D015228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Dyslipidemias[MeSHID:D050171] |
NA | phase 2 | unknown |
| ari-3037mo | hydroxycarboxylic acid receptor 3 | NA | Clinical trial target | TTD , DGIDB | Hypertriglyceridemia[MeSHID:D015228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cardiovascular Diseases[MeSHID:D002318] Dyslipidemias[MeSHID:D050171] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||